The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

( NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

The FDA on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

such as obstructive sleep apnea. Scientists are studying weight-loss drugs for a broad array of conditions, including kidney ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...

In March, the weight loss drug Wegovy was FDA-approved to prevent strokes and heart attacks. Along with the GLP-1 prescriptions treating heart disease, sleep apnea and obesity, there has been an ...

The U.S. Food and Drug Administration on Friday approved ... for weight-loss medicines only when they're used for another indication, like reducing heart risks.The FDA approval for sleep apnea ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...